These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7560483)

  • 1. Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation.
    Webb AR; Mythen MG; Jacobson D; Mackie IJ
    Intensive Care Med; 1995 Jan; 21(1):84-93. PubMed ID: 7560483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation management associated with extracorporeal circulation.
    Sniecinski RM; Levy JH
    Best Pract Res Clin Anaesthesiol; 2015 Jun; 29(2):189-202. PubMed ID: 26060030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation in Critically Ill Adults during Extracorporeal Circulation.
    Buchtele N; Staudinger T; Schäfer AK; Bögl MS; Schoergenhofer C; Schwameis M
    Hamostaseologie; 2021 Aug; 41(4):294-306. PubMed ID: 33860514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticoagulation of extracorporeal circuit in critically ill patients].
    Mariano F; Triolo G
    G Ital Nefrol; 2007; 24(1):34-42. PubMed ID: 17342691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostasis and thrombosis in continuous renal replacement treatment.
    Oudemans-van Straaten HM
    Semin Thromb Hemost; 2015 Feb; 41(1):91-8. PubMed ID: 25590526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and anticoagulation in extracorporeal membrane oxygenation.
    Muntean W
    Artif Organs; 1999 Nov; 23(11):979-83. PubMed ID: 10564301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing the Precarious Hemostatic Balance during Extracorporeal Life Support: Implications for Coagulation Laboratories.
    Winkler AM
    Semin Thromb Hemost; 2017 Apr; 43(3):291-299. PubMed ID: 28166602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges with Navigating the Precarious Hemostatic Balance during Extracorporeal Life Support: Implications for Coagulation and Transfusion Management.
    Andrews J; Winkler AM
    Transfus Med Rev; 2016 Oct; 30(4):223-9. PubMed ID: 27543261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?].
    Jude B; Lasne D; Mouton C; de Moerloose P; ; ;
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):589-96. PubMed ID: 15234724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs.
    Francey T; Schweighauser A
    J Vet Intern Med; 2018 Jan; 32(1):147-156. PubMed ID: 29171099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring and management of anticoagulation in children requiring extracorporeal circulation.
    Malviya S
    Semin Thromb Hemost; 1997; 23(6):563-7. PubMed ID: 9469631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
    Krajewski S; Krauss S; Kurz J; Neumann B; Schlensak C; Wendel HP
    Thromb Res; 2014 Mar; 133(3):455-63. PubMed ID: 24359968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal life support: the precarious balance of hemostasis.
    Annich GM
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S336-42. PubMed ID: 26149045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation.
    Saini A; Spinella PC
    Clin Lab Med; 2014 Sep; 34(3):655-73. PubMed ID: 25168949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure.
    Davenport A; Will EJ; Davison AM
    Nephron; 1994; 66(4):431-7. PubMed ID: 8015647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation during extracorporeal circulation under conditions of an ongoing systemic inflammatory response syndrome: effects of heparin.
    Feindt P; Litmathe J; Boeken U; Gams E
    Perfusion; 2005 Jan; 20(1):11-5. PubMed ID: 15751665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic Changes During Extracorporeal Membrane Oxygenation: A Prospective Randomized Clinical Trial Comparing Three Different Extracorporeal Membrane Oxygenation Systems.
    Malfertheiner MV; Philipp A; Lubnow M; Zeman F; Enger TB; Bein T; Lunz D; Schmid C; Müller T; Lehle K
    Crit Care Med; 2016 Apr; 44(4):747-54. PubMed ID: 26646464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation.
    Fang ZA; Navaei AH; Hensch L; Hui SR; Teruya J
    Semin Thromb Hemost; 2020 Feb; 46(1):62-72. PubMed ID: 31858515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter.
    Arcangeli A; Rocca B; Salvatori G; Ciancia M; De Cristofaro R; Antonelli M
    Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.